Fig. 1From: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trialStudy design. NAFLD: non-alcoholic fatty liver disease; HOMA-IR, homeostasis model assessment for insulin resistance; INS, insulin; FBG, fasting blood glucose; IPAQ, International Physical Activity Questionnaire-Short Form; SpO2, oxygen saturation; BP, blood pressure; HR, heart rate; SCFAs, short chain fatty acidsBack to article page